Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

Squeezing savings from PCI

In a competitive environment, how can a hospital protect its profit margins? With PCI, shortening the length of stay and reducing risk may provide answers.

Transradial PCI trims hospital costs by $553

Using transradial rather than transfemoral access for PCI saves a hospital on average $553, according to an analysis published in the March issue of the American Heart Journal. Much of the decrease in costs was attributed to a shorter post-procedural length of stay, “and that [savings] went up to $1,000 in people who were at high risk to bleed,” the senior author told Cardiovascular Business. 

Devices on cusp: Renal denervation, valves, stents

Renal denervation systems, percutaneous aortic valve replacement technologies and bioabsorbable coronary stents lead the pack for innovative cardiovascular devices in Novation’s spring 2013 CV Watch report.

Oops again: CMS finds more errors in its readmissions penalties

If at first you don’t succeed, try, try again. That appears to be the mantra for the Centers for Medicare & Medicaid Services (CMS), which once again revised penalties for preventable hospital readmissions for MI, heart failure and pneumonia.

Most states flunk pricing transparency test

Only two states received a grade of A for having laws that advance transparency of healthcare pricing. More than half the states in the union earned an F for failing to ensure consumers have access to pricing information.

ACC: With model, fewer fears of bumbling through bundling

SAN FRANCISCO—Hospitals may be able to stay one step ahead as healthcare marches toward bundled payments if a piloted model unveiled March 9 proves robust. The pilot study was presented in a poster at the American College of Cardiology (ACC) scientific session.

ACC: Apixaban more resource-friendly than warfarin

SAN FRANCISCO—Treating atrial fibrillation patients with apixaban may lighten the burden on the healthcare system, according to a poster presentation March 10 at the American College of Cardiology (ACC) scientific session. The analysis of ARISTOTLE data gave apixaban an edge over warfarin for resource use.

ACC: 4 steps to fair market value at the 5-year mark

SAN FRANCISCO—Cardiology practices can position themselves optimally for renegotiating fair market value after the initial five-year contract by employing thorough and deliberate preparation strategies, according to a presentation March 10 at the American College of Cardiology (ACC) scientific session.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.